Mammography Market Size, Share, and Trends 2024 to 2034

Mammography Market Size to Reach USD 4.75 Bn by 2032

The global mammography market size was estimated at USD 2.25 billion in 2022 and is expected to surpass around USD 4.75 billion by 2032 and growing at a CAGR of 7.80% over the forecast period 2023 to 2032.

Key Takeaways: 

• By product, U.S. mammography market was valued at USD 674 million in 2022 and is registering growth at a CAGR of 10% from 2023 to 2032.
• North America ruled the market and represented the biggest share of around 43% in 2022. 
• The breast tomosynthesis technology segment is projected to grow at a CAGR of 7% from 2023 to 2032.
• By technology, the digital mammography innovation segment accounted 69% revenue share in 2022.
• By product, the digital systems segment has garnered 63% market share in 2022.
• The 3D systems product segment is expected to reach at a 9.2% over the forecast period.

Growth Factors

Mammography is only X-beam photo of women breast. Mammography works with the location of breast malignant growth and other breast related sicknesses. These tests are utilized for screening and finding of Breast cancer among women. Expansion in geriatric populace, proactive drives by medical care associations to bring issues to light about early identification of Breast cancer, and upsurge in occurrence pace of Breast cancer are supposed to drive the market development. Besides, better repayment insurance contracts, expanded government financing for Breast cancer research, and mechanical headways, for example, breast tomosynthesis, which assists in simple recognition of breast malignant growth in women with thick breast tissues, fuel the interest for mammography systems.

Rising medical care uses, a flourishing medical services business, and a developing longing for successive checking are only a couple of the key drivers anticipated to drive interest for mammography machines later on years. Developing government drives to improve clinical translation and elevate admittance to mammary organ malignant growth screening systems are probably going to fuel interest all through the projected period. Notwithstanding these actions, the Health Resources and Services Administration (HRSA) laid out Federal Consolidated Health Centers Programs to further develop screening processes in restoratively burdened networks. New York State is supporting admittance to early breast malignant growth screening under Governor Cuomo. The exercises framed above are pointed toward helping patients whose family pay falls underneath the government neediness line.

Additionally, the some of the other considerations liable for the development of the mammography market incorporate the developing commonness of Breast cancer, mechanical headways in breast imaging, and venture from different associations in breast malignant growth screening efforts. As per a Globocan report in 2020, breast malignant growth was the most common sort of disease, with a predominance pace of 11.7%. As indicated by a similar report, the five-year commonness rate for both the genders showed that Asia had the biggest number of individuals impacted at 3,218,496 (41.3%), trailed by Europe at 2,138,117 (27.4%) and North America with 1.189,111 individuals (15.3%). Such high pervasiveness paces of Breast cancer are one of the fundamental reasons the interest for mammography gadgets is supposed to increment, as they might be utilized for indicative purposes.

Besides, according to the information distributed by United States, in October 2021, the all-out number of mammography methodology performed across the United States was around 38,698,995. In this way, the rising number of mammography tests performed is probably going to decidedly affect the development of the market in nations, similar to the United States. Subsequently, the previously mentioned factors help in driving the development of the market considered. Many significant tech organizations are utilizing AI (man-made brainpower) models that can naturally identify breast malignant growth. For example, in June 2020, Vara, a Berlin-based organization brought EUR 6.5 million up in Series A financing for AI-controlled breast malignant growth screening programming. These projects and mechanical headways related with mammograms are supposed to support market development.

Breast cancer is one of the huge medical problems for women around the world. For example, in 2022, an expected 287,850 new instances of obtrusive Breast cancer are supposed to be analyzed in women in the U.S., alongside 51,400 new instances of harmless breast malignant growth. Around 1 of every 8 U.S. women (around 13%) can foster obtrusive Breast cancer throughout her lifetime. This is expected to support the interest for mammography systems market. This market is supposed to observe huge development during the estimate time frame because of expansion in occurrence of Breast cancer, ascend in geriatric populace, and proactive drives by medical services associations to bring issues to light about early recognition of breast malignant growth. Also, better repayment insurance contracts, expanded government financing for Breast cancer research, and mechanical headways, for example, the breast tomosynthesis, which assists in simple location of breast malignant growth in women with thick breast tissues, fuel the interest for mammography systems.

The rising predominance of breast malignant growth and expanding interest for beginning phase finding among patients are a portion of the key elements expected to drive interest for Breast cancer demonstrative gadgets over the estimate period. Expanded admittance to Breast cancer screening systems and developing government drives to help clinical understanding are a portion of the crucial variables expected to move market development. For example, the Health Resources and Services Administration (HRSA) had acquainted a medical services program with increment the screening methodology in medicinally underserved regions.

The rising occurrence of breast cancer across the globe is one of the central point liable for the development of the market for mammography. For example, as per WHO, in 2018, around 627,000 women kicked the bucket because of Breast cancer in 2018 universally, and it is additionally assessed that the pace of breast malignant growth is higher among women in created districts when contrasted with creating areas. Also, as per Cancer Organization India, in 2018, breast and oral hole disease represented 25.0% of malignant growth cases in women. Besides, as per Susan G Komen Breast Cancer Foundation, Inc., in 2019, around 41,760 women are supposed to pass on because of Breast cancer. Moreover, as per South African Journal of Radiology, in 2018, breast malignant growth is one of the most well-known kinds of disease in South Africa in women and is likewise one of the main sources of death.

The presentation of new items in the market is supposed to support the reception rate among end-clients. The prior ages of mammography systems gave 2D pictures of the breast, which restricts the understanding quality. 2D mammography systems give Craniocaudal (CC) and Mediolateral-Oblique (MLO) pictures. The level idea of these pictures makes it hard for doctors to decipher pictures and distinguish growths because of covering of tissues and calcifications, which veils carcinogenic injuries. With the presentation of new 3D-based innovation called Digital Breast Tomosynthesis (DBT), getting a 3D picture of the breast is conceivable. This permits radiologists to filter the breast cut by cut and distinguish irregularities, which would be clouded in 2D pictures.

Report Scope of the Mammography Market

Product Insights

The digital systems section ruled the mammography market and represented the biggest market share in 2022 and is supposed to observe significant development over the gauge period. Rising interest for mechanically further developed Breast cancer screening systems is one of the fundamental variables expected to drive the market. The 3D framework is expected to be the quickest developing section with a CAGR of 12.1%. Government provided Acts, for example, Medical Imaging Modernization Act, 2015, appointed to advance mechanical headways, brought about a flood of interest for 3D systems.

The 3D systems portion is expected to be the quickest developing section over the gauge period. Attributable to a few benefits, clinics, and demonstrative facilities are changing to 3D systems as 2D systems are much of the time insufficient in identifying each indication of disease, expanding the requirement for extra screenings, which, thus, builds the generally symptomatic expense. The 3D systems market has become so aggressive that organizations, for example, Hologic have started publicizing their items straightforwardly to clients.

Technology Insights

In 2022, the digital mammography innovation segment accounted largest revenue share. Mechanical headways in the breast malignant growth screening gadgets market are expected to improve the usage and reception of computerized mammography. The breast tomosynthesis innovation portion is supposed to observe the quickest development over the estimate period.

Likewise, immense business accessibility and rising interest for mammography innovation among medical services experts are factors driving the portion. A portion of the central participants working significantly in this section are Siemens Healthcare Private Limited and General Electric Company (GE Healthcare). In 1996, computerized innovation was presented in these gadgets as a model innovation. Starting around 2015, it has turned into an experienced portion of the market.

Region Insights

North America dominated the market in 2022. The district is supposed to display an impressive development rate over the conjecture period. The rising frequency of breast malignant growth is one of the main considerations driving the market in the district. Moreover, the presence of profoundly evolved medical services framework and expanding medical services spending are among factors expected to drive the market in the district over the figure period.

In Asia Pacific, the market is expected to observe the quickest development over the estimate period. The presence of agricultural nations, like China, and Japan, is expected to help market development in Asia Pacific district. What's more, vital participants are putting forth steady attempts to enter developing business sectors of Asia Pacific, as would be considered normal to help the market over the estimate period.

As a result of the rising recurrence of breast malignant growths and rising per capita medical services spending nearby, the mammography market in the Americas is anticipated to overwhelm the worldwide business. Breast cancer is the best reason for mortality in women, as per the World Health Organization (WHO), with north of 2,000,000 new cases analyzed every year.

Europe's market is extending at a fast speed. This is because of the presence of a deeply grounded medical services framework and rising government motivations for the improvement of creative therapy options and is supposed to introduce the mammography piece of the pie with solid development potential. The presentation of cutting-edge 3D mammography innovation, for instance, has expanded the effectiveness of Breast cancer activities and treatments. The Asia-Pacific market is supposed to create at a consistent rate during the conjecture time frame, inferable from rising patient consciousness of Breast cancer and an expansion in the quantity of government endeavors for medical services change.

Key Market Developments

• In December 2020, Hologic Inc., an engineer, maker, and supplier of top-notch diagnostics, clinical imaging gadgets reported U.S. FDA leeway for its Genius AI Detection innovation, another profound learning-based programming intended to help radiologists to distinguish unpretentious expected diseases in breast tomosynthesis pictures.
• Hologic Inc. also, RadNet laid out collaboration in November 2020 to work on the improvement of man-made brainpower arrangements in breast wellbeing. The understanding will involve information trade, innovative work, and redesigning of RadNet's armada of Hologic mammography gadgets to state-of-the-art imaging innovation.
• GE Healthcare and Candelis Inc. declared collaboration in September 2020 to further develop mammography work process, picture the executives, and capacity abilities for the Senographe Pristina Mammography System.
• The key market players are constantly engaged in various developmental strategies like partnership, collaborations, new product launches, and acquisitions to strengthen their market position and gain market share.

Some of the prominent players:

• Hologic
• Fujifilm
• Siemens Healthcare
• Phillips Healthcare
• Toshiba Medical Systems
• GE Healthcare
• Metaltronica
• I.M.S. Srl
• Koninklijke Philips NV
• Gamma Medica, Inc.
• Konica Minolta Business Solutions India Private Limited
• Carestream Health.
• BMI Biomedical International SRL
• Canon Inc
• MetaltronicaSpA, PLANNED OY
• GENERAL MEDICAL ITALIA
• Villa Systems Medical SpA

Segments Covered in the Report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Product

• Film Screen Systems
• Digital Systems
• Analog Systems
• Biopsy Systems
• 3D Systems
• Others

By Technology

• Breast Tomosynthesis Mammography
• CAD Mammography
• Digital Mammography

By Modality

• Portable
• Non-Portable

By End Use

• Hospitals
• Special Clinics
• Diagnosis Centers
• Ambulatory Surgical Centers
• Educational & Research Institutes

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa